| Dr James Alexander Martin, AUD | |
|
480 23rd St, Ashland, KY 41101-7858 | |
| (606) 327-6202 | |
| Not Available |
| Full Name | Dr James Alexander Martin |
|---|---|
| Gender | Male |
| Speciality | Audiologist |
| Location | 480 23rd St, Ashland, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710909049 | NPI | - | NPPES |
| 50000108 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | KY-0334 (Kentucky) | Primary |
| 231H00000X | Audiologist | 01147 (Ohio) | Secondary |
| 237600000X | Audiologist-hearing Aid Fitter | 0770 (Kentucky) | Secondary |
| Provider Name | Mobile Medical Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1689620015 PECOS PAC ID: 5890765481 Enrollment ID: O20040730000013 |
News Archive
CEL-SCI Corporation announced today that its Taiwanese partner, Orient Europharma, has concluded the Site Initiation Visit for the first Taiwanese clinical center in CEL-SCI's Phase III clinical trial for Multikine, the Company's flagship cancer immunotherapy. The first center is called Shin Kong Wu Ho-Su Memorial Hospital and is located in Taipei, Taiwan.
Cancer occurs when human cells move and multiply inappropriately. Within cells, a process called phosphorylation serves as an on/off switch for a number of cellular processes that can be involved in cancer, including metabolism, transcription, configuration, movement, cell death and differentiation. This process is controlled by a group of enzymes called protein kinases that - working together and separately - modify the structure of proteins, changing them and allowing them to control cellular processes.
Glenmark Pharmaceuticals Limited announced today that the US Food and Drug Administration has provided Marketing approval to its partner in US, Salix Pharmaceuticals Limited, for Crofelemer 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in patients with human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) on anti-retroviral therapy (ART).
Iron accumulation in myocardial cells, potentially resulting in heart failure or fatal arrhythmia, is one of the complications most feared by patients with thalassemia major, a hereditary disease also known as Mediterranean anemia.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Alexander Martin, AUD 480 23rd St, Ashland, KY 41101-7858 Ph: (606) 327-6202 | Dr James Alexander Martin, AUD 480 23rd St, Ashland, KY 41101-7858 Ph: (606) 327-6202 |
News Archive
CEL-SCI Corporation announced today that its Taiwanese partner, Orient Europharma, has concluded the Site Initiation Visit for the first Taiwanese clinical center in CEL-SCI's Phase III clinical trial for Multikine, the Company's flagship cancer immunotherapy. The first center is called Shin Kong Wu Ho-Su Memorial Hospital and is located in Taipei, Taiwan.
Cancer occurs when human cells move and multiply inappropriately. Within cells, a process called phosphorylation serves as an on/off switch for a number of cellular processes that can be involved in cancer, including metabolism, transcription, configuration, movement, cell death and differentiation. This process is controlled by a group of enzymes called protein kinases that - working together and separately - modify the structure of proteins, changing them and allowing them to control cellular processes.
Glenmark Pharmaceuticals Limited announced today that the US Food and Drug Administration has provided Marketing approval to its partner in US, Salix Pharmaceuticals Limited, for Crofelemer 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in patients with human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) on anti-retroviral therapy (ART).
Iron accumulation in myocardial cells, potentially resulting in heart failure or fatal arrhythmia, is one of the complications most feared by patients with thalassemia major, a hereditary disease also known as Mediterranean anemia.
› Verified 4 days ago
Dr. Elizabeth Ellen Snyder, AUD CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: Box 11, 5850 Us 60, Ashland, KY 41102 Phone: 606-929-9155 Fax: 606-929-9833 | |
Dr. Melody Danielle Prouse, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1101 Saint Christopher Dr, Suite 350, Ashland, KY 41101 Phone: 606-836-3681 Fax: 606-834-8518 |